This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 167, 106009
Citation
Wang, Dan; Cheng, Lu; Li, Jieru; Deng, Bochuan; Yan, Tiantian; Yue, Xin; Zhang, Jianfeng; Zhang, Bangzhi; Xie, Junqiu. (2021). Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro.. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 167, 106009. https://doi.org/10.1016/j.ejps.2021.106009